Natalie C. Kennedy

Natalie C. Kennedy is a patent litigation attorney with a practice focused on complex disputes within the biotechnology, life sciences, and pharmaceutical sectors. Her experience includes handling Hatch-Waxman and biosimilar litigation. She demonstrates versatility in her practice, representing both plaintiffs and defendants in patent infringement matters, as evidenced by her role as Lead Counsel for a plaintiff and of counsel for a defendant in tracked cases.

Ms. Kennedy is currently affiliated with Weil, Gotshal & Manges LLP. Prior to her current role, she held positions at other notable firms, including as an associate at Jones Day and as counsel at Paul, Weiss, Rifkind, Wharton & Garrison LLP. She has played key roles in significant patent cases, acting as Lead Counsel for Regeneron Pharmaceuticals, Inc. in its litigation against Celltrion, Inc., a component of the broader Aflibercept Patent Litigation concerning biosimilar versions of a prominent ophthalmic product. She also served as of counsel for NanoString Technologies, Inc., defending against patent infringement allegations brought by 10x Genomics, Inc. et al., involving spatial biology technologies.

While specific details regarding her regular appearance in PTAB or IPR proceedings were not readily available in public search results, her academic background underpins her technical capabilities. She holds a B.A. from Swarthmore College (2007), an M.S. (2009) and a Ph.D. (2012) from the University of Virginia, and a J.D. from Fordham University (2016), where she graduated magna cum laude and was inducted into the Order of the Coif. Ms. Kennedy is admitted to practice in New Jersey (2016) and New York (2018), and is registered to practice before the U.S. Patent and Trademark Office.